SpaceX's Analyst Range Is a Wild 7x: From $115 to $800 as Stock Drops Below IPO Price

SpaceX stock hits new lows after $4B index buying fails; lockup unwind could flood market with 900% more shares. Analyst price targets range from $115 to $800.

The spectacle surrounding SpaceX’s publicly traded equity has reached a fever pitch. On July 10, Elon Musk took to X to declare that his rocket company could one day be “worth more than the rest of the world together”—a claim that rang hollow as the stock that same day slid below its $150 initial public offering price, touching a fresh low of $145.07. The divergence between Musk’s vision and the market’s reality is stark, but it is the split among Wall Street analysts that best captures the confusion: price targets range from a bearish $115 from CFRA to a stratospheric $800 from Raymond James, making this one of the most polarized coverage universes in recent memory.

That $115-to-$800 spread—a gap of nearly 600%—is not merely a difference of opinion; it reflects a fundamental disagreement about whether SpaceX is a pre-profit infrastructure company, a hyped AI proxy, or a speculative bubble. Raymond James analyst Brian Gesuale, whose $800 target is the highest on the Street, is betting that Starlink and Starship will propel revenue from roughly $38.5 billion today to over $837 billion by 2031, with EBITDA reaching $696 billion. At the opposite end, CFRA’s sell rating at $115 implies that the risk of lock-up selling, heavy cash burn, and competition in AI from Anthropic and OpenAI outweighs any long-term optionality. Lying between these poles are Deutsche Bank at $255, Macquarie at $250, Clear Street at $217, and Morgan Stanley, which offers a range from a pessimistic $75 to an optimistic $600. Even the consensus—around $237 to $240 per data from major surveys—is nearly 60% above the current price, yet the stock keeps falling.

A $4 Billion Index Influx That Failed

The most striking evidence that supply is overwhelming demand came just days after the stock’s July 7 inclusion in the Nasdaq 100. Under an expedited entry rule, SpaceX joined the index only 15 trading days after its June 12 IPO, triggering forced buying of roughly $4 billion from index-tracking funds. Instead of rallying, the stock plunged 6.8% on the first day of inclusion and fell further to a then-record low of $145.20 the next day. Market observers described it as a failed test of supply-demand mechanics: a wave of buying that normally provides a floor instead confirmed that there are too many shareholders eager to exit.

That exit pressure is about to intensify. The lock-up agreements that artificially capped the float at just 4% of the 13.17 billion outstanding shares—a constraint that propelled the stock to its all-time high of $225.64 on June 16—are beginning to unwind. According to 22V Research strategist Jeff Jacobson, insiders could sell up to 44% of total shares by early September, increasing the tradable float by roughly 900%. The timeline is staggered: 20% of early-released shares become tradable after the first quarterly report as a public company (set for August 6), followed by an additional 10% if the stock trades 30% above the IPO price. Further tranches of 7% are scheduled for August 21 and September 10. Elon Musk and certain other insiders remain locked for 366 days, but employee and early investor selling could free up as much as 83% of the non-long-term restricted float by the third quarter of 2026, according to the secondary source.

The Financial Reality Beneath the Hype

The disconnect between optimism and price may reflect a company that is financially schizophrenic. Starlink, the broadband satellite unit, generated $11.4 billion in revenue in 2025—61% of the total $18.7 billion—and posted an operating profit of $4.4 billion. Adjusted earnings reached $7.2 billion, up 86% year over year, and subscribers now exceed 7 million. The launch business contributed another $4.1 billion. But those profits are being devoured by SpaceX’s AI arm, xAI, which produced $3.2 billion in revenue but an operating loss of $6.4 billion. Advisorpedia projects the unit’s annual loss could approach $10 billion in 2026. On a consolidated basis, SpaceX reported a net loss of $4.9 billion in 2025 on $20.7 billion in capital spending. In the first quarter of 2026, revenue hit $4.7 billion with an adjusted EBITDA of $1.1 billion, but the loss per share came in at $1.27. Government contracts, including a $2.29 billion Space Force award in May, account for roughly one-fifth of sales.

Given the cash incineration, it is perhaps unsurprising that the stock has shed 36% of its value in just 22 trading days—a $1.05 trillion market-capitalization loss. Even the most bullish analyst targets, which imply 87% upside from recent levels around $148, have failed to stanch the bleeding. Critics like GMO co-founder Jeremy Grantham have been vocal: he called the $1.7 trillion valuation “remarkable” for a loss-making company whose growth narrative relies heavily on an AI offering that is losing ground to Anthropic and OpenAI. Grantham also accused Nasdaq of bending its rules to include SpaceX despite its lack of profitability.

Catalysts That Could Tip the Balance

The market is now fixated on two events that could either confirm the bears or vindicate the bulls. The first is SpaceX’s inaugural quarterly report as a listed company on August 6, which will provide the first detailed look at post-IPO financials and trigger the initial lock-up release. The second is the 13th Starship test flight, scheduled for July 15, following a successful static fire test of Booster 20’s 33 Raptor 3 engines. Raymond James’s Gesuale and other Starship bulls argue that successful orbital flights could reduce transport costs by more than 99%, unlocking a market addressable at roughly $30 trillion. Seekers of a fair value, however, point to a discounted cash-flow model by Seeking Alpha that puts intrinsic worth at just $90.41, and to the fact that Starship has only flown 12 test missions to date.

Until those events pass, the stock’s trajectory remains hostage to a tug-of-war between forced buying from index rebalancing—now exhausted—and an impending wave of insider selling. With a GF Value Score of just 12 out of 100 and a price-to-sales ratio of 76.8, even the optimists acknowledge that SpaceX remains a story stock whose next chapter has yet to be written. Whether that story is a buying opportunity or the prelude to a larger correction may be decided in the space of a few weeks.